3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase 1/2
5
Phase 1
2
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
207
Neoplasms
130
Polycystic Ovary Syndrome
107
Carcinoma, Hepatocellular
82
Colorectal Neoplasms
77
Prostatic Neoplasms
70
Stomach Neoplasms
55
Lung Neoplasms
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Carcinoma, Non-Small-Cell Lung
43
Pancreatic Neoplasms
41
Pain, Postoperative
41
Head and Neck Neoplasms
38
Pain
37
Liver Neoplasms
36
Leukemia, Myeloid, Acute
32
Leiomyoma
32
Keratosis, Actinic
31
Colonic Neoplasms
31
Recurrence
30
Neoplasm Metastasis
29
Multiple Myeloma
28
Infertility
28
Brain Neoplasms
28
Uterine Cervical Neoplasms
26
Urinary Bladder Neoplasms
24
Ovarian Neoplasms
24
Lymphoma
24
Esophageal Neoplasms
23
Obesity
22
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Clear all
NCT05235737
2023-08-31
PIRG
Medical University of Silesia
Phase 4
Unknown
36 enrolled